Skip to main content
Peter Kouides, MD, Hematology, Rochester, NY, Rochester General Hospital

PeterAKouidesMD

Hematology Rochester, NY

Clotting Disorder, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Medical and research director, Mary M. Gooley Hemophilia center, Clinical Professor of Medicine University of Rochester School of Medicine

Dr. Kouides is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kouides' full profile

Already have an account?

Summary

  • Dr. Peter Kouides is an oncologist in Rochester, NY and is affiliated with Rochester General Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice 31 years. He specializes in hematologic oncology and is experienced in thrombotic disorders, bleeding disorders, general / benign hematology, and anemia.

Education & Training

  • University of Rochester
    University of RochesterFellowship, Hematology and Medical Oncology, 1989 - 1993
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 1986 - 1989
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1986

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1989 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study
    Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular Interventions
    Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn Dataset
    Peter A. Kouides, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations